Potent inhibitor of EGFR tyrosine kinase (IC50 = 2 nM)1. Potent inhibitor of mutant JAK2-V617F2. Weaker inhibitor of ErbB-2 kinase (Ki = 1 µM) ErbB-4 kinase (Ki = 1.5 µM)3. HDAC inhibitors sensitize for erlotinib activity in EGFR-mutated and wildtype non
* VAT and and shipping costs not included. Errors and price changes excepted